Clinical Interests

Biocompatibility of Contact Lenses
Dry Eye Tear Film Characteristics
Drug Delivery Devices

Research

Biocompatibility of synthetic and bio-polymers in the ocular environment. This involves analyzing the polymer surface and the adjacent tissue on a submicroscopic level for chemical changes in the polymer, deposition of protein and cofactors onto the polymer, chemical changes in the extracellular matrix adjacent to the polymer surface, and quantitative differences in the composition in the adjacent tissue (for example, number of macrophages, types of collagen present).

Dr. Jacob’s investigation into the biocompatibility response around ocular implants has led to improvements in several basic implant designs (artificial cornea, total ocular replacement devices, reinforcement membranes, and glaucoma drains). It has also led to the identification of ways to alter the conformation of the implant surface in order to increase cellular infiltration and, thereby, improve implant stabilization in the biological milieu.

Current research projects include dry eye modeling and analysis of tear components (proteins and lipids) using nano-scale HPLC and capillary electrophoresis-mass spectrometry, contact lens materials/wear analysis and testing, development and testing of biodegradable nerve guides for the enhanced regeneration of nerves after injury, and nanofilms development and the ability of specific surface-tethered proteins and amino-acid-sequence-containing peptides to promote epithelial spreading and adhesion to biomaterials.

Dr. Jacob has a national reputation in ophthalmic materials testing (mechanical, bulk material chemistry, biological, and surface chemistry) for industrial groups. In addition to contract materials testing, Dr. Jacob has developed new concepts (drug delivery), accompanying material requirements, and surgical models for specific ophthalmic devices (artificial corneas, synthetic corneal onlays, and accommodating intraocular lenses) on a contract basis for industry.

PATENTS:

Ocular drug delivery devices; Jean T. Jacob, Kevin J. Halloran, Yuri McKee, U.S. Patent Application No. 12/916,398: Filed 10-27-2010.

Bioartificial Lacrimal Gland; Samuel Yiu, Jean T. Jacob, Austin Mircheff, Melvin Trousdale, US Pat#7,547,447: Issued, 6-16-2009.

Surface Modifications for Enhanced Epithelialization; Jean T. Jacob, Jingjing Bi, US Pat   #6,689,165: Issued, 2-10-04.

Long-Term Glaucoma Drainage Implant; Jean T. Jacob, US Pat #5,882,327: Issued, 3-16-99.

Ocular Prosthesis with Cellular Attachment; Jean T. Jacob-LaBarre, US Pat #5,282,851: Issued, 2-1-94.  

Total Ocular Replacement Apparatus with Muscle Attachment Sites; Jean T. Jacob-LaBarre, US Pat #5,192,315; Issued, 3-9-93.

An Accommodating Intraocular Lens; Jean T. Jacob-LaBarre and D.R. Caldwell, US Pat #4,932,968; Issued, 6-12-90.

A Soft Keratoprosthesis; Jean T. Jacob-LaBarre and D.R. Caldwell, US Pat # 4,865,601; Issued, 9-12-89.

Publications

Jacob JT, Levet Jr J, Edwards TA, Dassanayake N, Ketelson H: Visualization hydrophobic domains in silicone hydrogel lenses with Sudan IV. Invest Ophth Vis Sci, 2012; 53:3473-3480.

Jacob JT, Ham BM: Compositional profiling and biomarker identification of the tear film. Ocular Surface, 2008; 6:175-185.

Booth BA, Vidal Denham L, Bouhanik S, Jacob JT, Hill JM, Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications. Drugs Aging. 2007;24:581-602.

Ham BM, Jacob JT, Cole R: Single eye analysis and contralateral eye comparison of tear proteins in normal and dry eye model rabbits by MALDI_ToF mass spectrometry using wax-coated target plates. Anal Bioanal Chem, 387:889-900, 2007. PM:17211596

Selvam S, Thomas PB, Trousdale MD, Stevenson D, Schechter JE, Mircheff AK, Jacob JT, Smith RE, Yiu SC: Tissue-engineered tear secretory system: Functional lacrimal gland acinar cells cultured on matrix protein-coated substrata. J Biomed Mater Res B Appl Biomater,80: 192-200, 2007. PM:16850479

Ham BM, Cole R, Jacob JT: Identification and comparison of the polar phospholipids in normal and dry eye rabbit tears by maldi-TOF mass spectrometry. Invest Ophthalmol Vis Sci, 47 (8):3330-3338, 2006. PM:16877399

Ham BM, Jacob JT, Cole RB: MALDI-TOF MS of phosphorylated lipids in biological fluids   using immobilized metal affinity chromatography and a solid ionic crystal matrix. Anal Chem, 77:4439-4447, 2005. PM:16013857 

Jacob JT, Rochefort J, Bi J, Gebhardt BM: Corneal epithelial cell growth over tethered-protein/peptide surface-modified hydrogels. J Biomed Mater Res, Part B., 72B:198-205, 2005. PM:15486971

Wallace C, Jacob JT, Stoltz A, Bi J, Bundy K: Corneal epithelial adhesion strength to tethered-protein/peptide modified hydrogel surfaces. J Biomed Mater Sci, Part A., 72A(1):19-24, 2005. PM:15534866

Ham BM, Jacob JT, Keese MM, Cole RB: Identification, quantification and comparison of major non-polar lipids in normal and dry eye tear lipidomes by electrospray tandem mass spectrometry. J Mass Spectrometry, 39(11):1321-1336, 2004.  PM:15532045

Bi J, Downs C, Jacob JT: Tethered protein/peptide-surface-modified hydrogels. J Biomater Sci Polymer Edn 15(7):905-916, 2004. PM:15318800

Teaching

Dr. Jacob has directed the biomaterials research activities of over 76 resident, medical, graduate, and undergraduate students in all areas of ophthalmic devices and drug delivery systems.